Valneva (VALN) News Today

→ Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad)

$7.93

-0.20 (-2.46%)

(As of 11:44 AM ET)

Source

Source	Headline
	Valneva (NASDAQ:VALN) Shares Down 3.9% marketbeat.com - April 19 at 12:24 PM
	Valneva (NASDAQ:VALN) Trading 6.1% Higher marketbeat.com - April 18 at 4:55 PM
	Valneva (NASDAQ:VALN) Shares Gap Down to $8.50 marketbeat.com - April 16 at 11:56 AM
	Valneva (NASDAQ:VALN) Shares Gap Up to $8.04 americanbankingnews.com - April 12 at 4:30 AM
	Valneva (NASDAQ:VALN) Stock Price Up 4.3% marketbeat.com - April 11 at 1:47 PM
	Valneva (NASDAQ:VALN) Trading Down 6.6% marketbeat.com - April 9 at 2:46 PM
	Declaration of voting rights - Valneva SE, March 2024 finance.yahoo.com - April 4 at 3:56 PM
	Valneva (NASDAQ:VALN) Shares Gap Up to $7.72 marketbeat.com - April 3 at 4:50 PM
	Valneva (NASDAQ:VALN) Shares Gap Down to $7.92 marketbeat.com - April 1 at 2:01 PM
	Short Interest in Valneva SE (NASDAQ:VALN) Increases By 49.8% marketbeat.com - March 29 at 7:20 AM
	Valneva commences Phase I trial of second-generation Zika vaccine msn.com - March 27 at 6:21 PM
	Valneva (NASDAQ:VALN) Stock Price Down 4.1% marketbeat.com - March 27 at 4:44 PM
	Buy Rating on Valneva Supported by Promising Vaccine Developments and Solid Revenue Projections markets.businessinsider.com - March 27 at 3:20 AM
	Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate globenewswire.com - March 26 at 2:00 AM
	2 new Lyme disease vaccines could mean end of debilitating illness msn.com - March 25 at 10:12 PM
	Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F globenewswire.com - March 25 at 2:00 AM
	Valneva SE (VALN) Q4 2023 Earnings Call Transcript seekingalpha.com - March 22 at 7:10 PM
	What Analysts Are Saying About Valneva Stock markets.businessinsider.com - March 22 at 7:10 PM
	Valneva (NASDAQ:VALN) PT Lowered to $17.00 marketbeat.com - March 22 at 2:58 PM
	Buy Rating Affirmed for Valneva: Strong Core Growth and Strategic Financial Health markets.businessinsider.com - March 21 at 11:05 PM
	Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript finance.yahoo.com - March 21 at 6:05 PM
	Valneva (NASDAQ:VALN) Shares Gap Up to $7.10 marketbeat.com - March 21 at 3:14 PM
	HC Wainwright Reaffirms Buy Rating for Valneva (NASDAQ:VALN) marketbeat.com - March 21 at 8:22 AM
	Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C. globenewswire.com - March 21 at 2:00 AM
	Valneva guides for nearly double product sales by 2026 msn.com - March 20 at 6:00 PM
	VALN Stock Earnings: Valneva Misses Revenue for Q4 2023 investorplace.com - March 20 at 1:14 PM
	Valneva GAAP EPS of -€0.73, revenue of €153.71M; updates FY24 guidance msn.com - March 20 at 5:22 AM
	Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook finance.yahoo.com - March 20 at 5:22 AM
	French biotech company Valneva raises product sales guidance reuters.com - March 20 at 2:48 AM
	Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook globenewswire.com - March 20 at 2:00 AM
	West Lothian sciences firm bags brace of awards msn.com - March 19 at 12:22 PM
	Valneva (NASDAQ:VALN) Trading 7.4% Higher marketbeat.com - March 19 at 11:56 AM
	Valneva (NASDAQ:VALN) Sees Strong Trading Volume marketbeat.com - March 18 at 11:25 AM
	Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed globenewswire.com - March 18 at 2:00 AM
	The UK could be a vaccine superpower, but it needs a booster ft.com - March 12 at 6:23 PM
	Lexicon stock rallies 18% amid FDA update, $250M private placement msn.com - March 11 at 3:28 PM
	Global Anthrax Vaccine Market Worth Over $22 Billion by 2034, Driven by Advanced Vaccine Developments and Rising Demand for Bioterrorism Defense finance.yahoo.com - March 11 at 3:28 PM
	VALNEVA Declaration of shares and voting rights - February 29, 2024 finance.yahoo.com - March 6 at 5:08 PM
	Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences globenewswire.com - March 4 at 1:00 AM
	Short Interest in Valneva SE (NASDAQ:VALN) Drops By 32.9% marketbeat.com - March 1 at 9:46 AM
	Buy Rating Affirmed for Valneva on Strong Vaccine Market Prospects and Positive Regulatory Developments markets.businessinsider.com - February 29 at 6:33 PM
	U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ® finance.yahoo.com - February 29 at 1:49 AM
	U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva's Single-Dose Chikungunya Vaccine IXCHIQ® globenewswire.com - February 29 at 1:00 AM
	Valneva SE (VLAP.XD) finance.yahoo.com - February 24 at 9:54 AM
	Novavax’s dispute resolution and upcoming earnings call (VALN) marketbeat.com - February 23 at 7:44 AM
	Valneva (NASDAQ:VALN) Hits New 52-Week Low at $7.38 marketbeat.com - February 20 at 10:59 AM
	Valneva reports FY results; initiates FY24 outlook msn.com - February 15 at 7:58 AM
	Valneva Annual Preliminary Revenue Down; Expects Product Sales To Rise In 2024 markets.businessinsider.com - February 15 at 7:58 AM
	Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance markets.businessinsider.com - February 15 at 7:58 AM
	Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance finance.yahoo.com - February 15 at 7:58 AM

Get Valneva News Delivered to You Automatically

Uncover this 2024 Hidden Gem (Ad)

Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.

[Click here to subscribe] and elevate your trading today.

VALN Media Mentions By Week

VALN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VALN
News Sentiment
▼
0.67

0.52
▲
Average
Medical
News Sentiment

VALN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VALN Articles
This Week
▼
3

3
▲
VALN Articles
Average Week

Get Valneva News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:VALN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Valneva (VALN) News Today

VALN Media Mentions By Week

VALN Media Sentiment

VALN News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info